e-Article
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'e-Article'
searched 8results | List
1~20
Bucktrout SL; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA. sbucktrout@parkerici.org.; Banovich NE; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.; Butterfield LH; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Cimen-Bozkus C; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Giles JR; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Good Z; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Stanford Cancer Institute and Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.; Goodman D; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Microbiology and Immunology, School of Medicine, University of California San Francisco, San Francisco, CA, USA.; Jonsson VD; Department of Applied Mathematics, University of California, Santa Cruz, Santa Cruz, CA, USA.; Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.; Genomics Institute, University of California, Santa Cruz, Santa Cruz, CA, USA.; Lareau C; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Marson A; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Gladstone-UCSF Institute for Genomic Immunology, San Francisco, CA, USA.; Maurer DM; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Munson PV; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Stubbington M; 10x Genomics, Pleasanton, CA, USA.; Taylor S; 10x Genomics, Pleasanton, CA, USA.; Cutchin A; 10x Genomics, Pleasanton, CA, USA.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE
Academic Journal
Williams JH; Worldwide Research & Development, Pfizer Inc, 10777 Science Center Dr, CB1/1130, San Diego, California, 92121, USA. jason.williams@pfizer.com.; Udata C; Worldwide Research & Development, Pfizer Inc, 10777 Science Center Dr, CB1/1130, San Diego, California, 92121, USA.; Ganguly BJ; Pfizer Inc, South San Francisco, California, USA.; Lyell Immunopharma, South San Francisco, California, USA.; Bucktrout SL; Pfizer Inc, South San Francisco, California, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Joh T; Worldwide Research & Development, Pfizer Inc, 10777 Science Center Dr, CB1/1130, San Diego, California, 92121, USA.; Shannon M; Worldwide Research & Development, Pfizer Inc, 10777 Science Center Dr, CB1/1130, San Diego, California, 92121, USA.; Wong GY; Worldwide Research & Development, Pfizer Inc, 10777 Science Center Dr, CB1/1130, San Diego, California, 92121, USA.; Levisetti M; Worldwide Research & Development, Pfizer Inc, 10777 Science Center Dr, CB1/1130, San Diego, California, 92121, USA.; DNAtrix Therapeutics, San Diego, California, USA.; Garzone PD; Pfizer Inc, South San Francisco, California, USA.; Calibr, a division of Scripps Research, La Jolla, California, USA.; Meng X; Worldwide Research & Development, Pfizer Inc, 10777 Science Center Dr, CB1/1130, San Diego, California, 92121, USA.
Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE
Academic Journal
Herold, Kevan C; Bucktrout, Samantha L; Wang, Xiao; Bode, Bruce W; Gitelman, Stephen E; Gottlieb, Peter A; Hughes, Jing; Joh, Tenshang; McGill, Janet B; Pettus, Jeremy H; Potluri, Shobha; Schatz, Desmond; Shannon, Megan; Udata, Chandrasekhar; Wong, Gilbert; Levisetti, Matteo; Ganguly, Bishu J; Garzone, Pamela D
JCI Insight, vol 4, iss 24
Academic Journal
van Beek AA; Departments of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.; Zhou G; Departments of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.; Doukas M; Department of Pathology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.; Boor PPC; Departments of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.; Noordam L; Departments of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.; Mancham S; Departments of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.; Campos Carrascosa L; Departments of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.; van der Heide-Mulder M; Departments of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.; Polak WG; Department of Surgery, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.; Ijzermans JNM; Department of Surgery, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.; Pan Q; Departments of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.; Heirman C; Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium.; Mahne A; Cancer Immunology Discovery Unit, Pfizer Inc., South San Francisco, CA.; Bucktrout SL; Cancer Immunology Discovery Unit, Pfizer Inc., South San Francisco, CA.; Bruno MJ; Departments of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.; Sprengers D; Departments of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.; Kwekkeboom J; Departments of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Academic Journal
Genome Med
Genome Medicine, Vol 10, Iss 1, Pp 1-10 (2018)
Genome Medicine, vol 10, iss 1
Genome Medicine, Vol 10, Iss 1, Pp 1-10 (2018)
Genome Medicine, vol 10, iss 1
Academic Journal
Bucktrout SL; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA. sbucktrout@parkerici.org.; Banovich NE; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.; Butterfield LH; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Cimen-Bozkus C; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Giles JR; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Good Z; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Stanford Cancer Institute and Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.; Goodman D; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Microbiology and Immunology, School of Medicine, University of California San Francisco, San Francisco, CA, USA.; Jonsson VD; Department of Applied Mathematics, University of California, Santa Cruz, Santa Cruz, CA, USA.; Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.; Genomics Institute, University of California, Santa Cruz, Santa Cruz, CA, USA.; Lareau C; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Marson A; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Gladstone-UCSF Institute for Genomic Immunology, San Francisco, CA, USA.; Maurer DM; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Munson PV; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Stubbington M; 10x Genomics, Pleasanton, CA, USA.; Taylor S; 10x Genomics, Pleasanton, CA, USA.; Cutchin A; 10x Genomics, Pleasanton, CA, USA.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Academic Journal
Vence L; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Bucktrout SL; Cancer Immunology Discovery Unit, South San Francisco, California.; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Fernandez Curbelo I; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Blando J; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Smith BM; Cancer Immunology Discovery Unit, South San Francisco, California.; Mahne AE; Cancer Immunology Discovery Unit, South San Francisco, California.; Lin JC; Cancer Immunology Discovery Unit, South San Francisco, California.; Regeneron Pharmaceuticals Inc., Tarrytown, New York.; Park T; Cancer Immunology Discovery Unit, South San Francisco, California.; Pascua E; Cancer Immunology Discovery Unit, South San Francisco, California.; Sai T; Cancer Immunology Discovery Unit, South San Francisco, California.; Chaparro-Riggers J; Cancer Immunology Discovery Unit, South San Francisco, California.; Subudhi SK; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Scutti JB; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Higa MG; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Zhao H; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Yadav SS; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Maitra A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Allison JP; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Sharma P; The Immunotherapy Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas. PadSharma@mdanderson.org.; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Yost KE; Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA, USA.; Satpathy AT; Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA, USA. satpathy@stanford.edu.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA. satpathy@stanford.edu.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. satpathy@stanford.edu.; Wells DK; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Qi Y; Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA, USA.; Wang C; iRepertoire Inc, Huntsville, AL, USA.; Kageyama R; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; McNamara KL; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Granja JM; Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA, USA.; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.; Program in Biophysics, Stanford University School of Medicine, Stanford, CA, USA.; Sarin KY; Department of Dermatology, Stanford University School of Medicine, Redwood City, CA, USA.; Brown RA; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Dermatology, Stanford University School of Medicine, Redwood City, CA, USA.; Gupta RK; Stanford Biobank, Stanford University School of Medicine, Palo Alto, CA, USA.; Curtis C; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Bucktrout SL; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Davis MM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.; Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, CA, USA.; Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA, USA.; Chang ALS; Department of Dermatology, Stanford University School of Medicine, Redwood City, CA, USA. alschang@stanford.edu.; Chang HY; Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA, USA. howchang@stanford.edu.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. howchang@stanford.edu.; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA. howchang@stanford.edu.; Department of Dermatology, Stanford University School of Medicine, Redwood City, CA, USA. howchang@stanford.edu.; Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA, USA. howchang@stanford.edu.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Refining the search results
Facets
[AR] Bucktrout, Samantha L
Publication year
-
Database provider
Title
Publisher
자료유형(Source Type)
Subject
Language